92 related articles for article (PubMed ID: 17033501)
1. A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costs.
Song X; Huse DM; Williams SA; Borok GM; McDonough K; Ozminkowski RJ
J Occup Environ Med; 2006 Oct; 48(10):1014-22. PubMed ID: 17033501
[TBL] [Abstract][Full Text] [Related]
2. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial.
Ohsfeldt RL; Gandhi SK; Smolen LJ; Jensen MM; Fox KM; Gold A; Hsia J
J Med Econ; 2010; 13(3):428-37. PubMed ID: 20662625
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial.
Ohsfeldt RL; Olsson AG; Jensen MM; Gandhi SK; Paulsson T
J Med Econ; 2012; 15(1):125-33. PubMed ID: 22050473
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of high, moderate and low-dose statins in the prevention of vascular events in the Brazilian public health system.
Ribeiro RA; Duncan BB; Ziegelmann PK; Stella SF; Vieira JL; Restelatto LM; Polanczyk CA
Arq Bras Cardiol; 2015 Jan; 104(1):32-44. PubMed ID: 25409878
[TBL] [Abstract][Full Text] [Related]
6. Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?
Ara R; Pandor A; Stevens J; Rafia R; Ward SE; Rees A; Durrington PN; Reynolds TM; Wierzbicki AS; Stevenson M
Eur J Prev Cardiol; 2012 Jun; 19(3):474-83. PubMed ID: 21460076
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain.
Barrios V; Lobos JM; Serrano A; Brosa M; Capel M; Alvarez Sanz C
J Med Econ; 2012; 15 Suppl 1():45-54. PubMed ID: 22954062
[TBL] [Abstract][Full Text] [Related]
8. Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective.
Montouchet C; Ruff L; Balu S
J Med Econ; 2013 Jul; 16(7):907-16. PubMed ID: 23641809
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial.
Hirsch M; O'Donnell JC; Jones P
Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):18-28. PubMed ID: 15703502
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.
Peura P; Martikainen J; Soini E; Hallinen T; Niskanen L
Curr Med Res Opin; 2008 Jun; 24(6):1823-32. PubMed ID: 18485270
[TBL] [Abstract][Full Text] [Related]
11. An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.
Lorgelly PK; Briggs AH; Wedel H; Dunselman P; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J; Jánosi A; van Veldhuisen DJ; Barrios V; Fonseca C; McMurray JJ;
Eur J Heart Fail; 2010 Jan; 12(1):66-74. PubMed ID: 20023047
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.
Hirsch M; O'donnell J; Olsson A
Int J Cardiol; 2005 Oct; 104(3):251-6. PubMed ID: 16186052
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score in patients with elevated C-reactive protein.
MacDonald GP
J Am Osteopath Assoc; 2010 Aug; 110(8):427-36. PubMed ID: 20805548
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rosuvastatin every other day compared with once daily in patients with hypercholesterolemia.
Wongwiwatthananukit S; Sansanayudh N; Dhummauppakorn R; Kitiyadisai C
Ann Pharmacother; 2006 Nov; 40(11):1917-23. PubMed ID: 17003082
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of rosuvastatin in the prevention of ischemic heart disease in Portugal.
Pinto CG; Carrageta MO; Miguel LS
Value Health; 2008; 11(2):154-9. PubMed ID: 18380628
[TBL] [Abstract][Full Text] [Related]
16. The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Grover SA; Ho V; Lavoie F; Coupal L; Zowall H; Pilote L
Arch Intern Med; 2003 Feb; 163(3):333-9. PubMed ID: 12578514
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.
Benner JS; Smith TW; Klingman D; Tierce JC; Mullins CD; Pethick N; O'Donnell JC
Value Health; 2005; 8(6):618-28. PubMed ID: 16283862
[TBL] [Abstract][Full Text] [Related]
18. Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Kei A; Tellis C; Liberopoulos E; Tselepis A; Elisaf M
Cardiovasc Ther; 2014 Aug; 32(4):139-46. PubMed ID: 24618208
[TBL] [Abstract][Full Text] [Related]
19. Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
Roth EM; Rosenson RS; Jones PH; Davidson MH; Kelly MT; Setze CM; Lele A; Thakker K
J Clin Lipidol; 2012; 6(6):534-44. PubMed ID: 23312049
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.
Willich SN; Müller-Nordhorn J; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H
Am Heart J; 2004 Dec; 148(6):1060-7. PubMed ID: 15632894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
